Post archive with date 2013

All post items with date 2013

Treatment of Progressive multiple sclerosis (MS)

Progressive MS is a serious and severely disabling condition with a high unmet medical need”, said Dr. Peder Walberg, CEO of Medical Need, and continued: “MD-1003 has shown great promise for these severely affected patients which currently have a very poor prognosis and may represent a significant break-through in the treatment of progressive MS. We are delighted about this partnership with MedDay to advance the product in its development and make it available to the MS patients across Europe.

Read more